Pregnancy is an exciting journey, often accompanied by many questions for expectant mothers. Non-Invasive Prenatal Testing (NIPT) provides a highly accurate and comforting way to screen your baby for chromosomal conditions, requiring only a straightforward blood sample. The dedicated team of Amber Health obstetricians and gynecologists in Hong Kong is here to walk you through the NIPT test procedure with clear information, compassionate care, and the highest level of clinical excellence.
The NIPT test is an advanced prenatal screening that analyzes fetal DNA fragments circulating in the mother's bloodstream to detect potential chromosomal abnormalities in the developing baby. Because it requires only a maternal blood sample, the NIPT test poses absolutely no risk to the fetus, making it a safe, reliable, and increasingly preferred choice among expectant mothers.
The NIPT test offered at Amber Health screens for the following chromosomal conditions:
While Down Syndrome cannot be prevented, early detection through prenatal screening allows parents to understand potential risks and prepare for medical care and family support. At Amber Health, our T21 test forms part of our comprehensive prenatal health services, offering expectant mothers reassurance through accurate, non-invasive testing.
The NIPT test is an advanced prenatal screening that analyzes fetal DNA fragments circulating in the mother's bloodstream to detect potential chromosomal abnormalities in the developing baby. Because it requires only a maternal blood sample, the NIPT test poses absolutely no risk to the fetus, making it a safe, reliable, and increasingly preferred choice among expectant mothers.
The NIPT test delivers a detection accuracy rate of over 99% for chromosomal conditions such as Down Syndrome, significantly higher than traditional prenatal screening methods. This level of precision gives expectant parents greater confidence in their results and reduces the likelihood of unnecessary follow-up procedures.
Unlike diagnostic procedures such as chorionic villus sampling (CVS) or amniocentesis, the NIPT test requires only a single blood draw from the mother. There is no needle near the uterus, no risk of miscarriage, and no discomfort beyond a routine blood test — making it a safe option for both mother and baby.
The NIPT test can be performed as early as 10 weeks into pregnancy, earlier than many traditional screening methods. This allows expectant parents to receive important information sooner, providing more time to consider their options, seek further testing if needed, and prepare for the journey ahead.
Results are typically available within 5–7 working days, helping to minimize the anxiety that can accompany the waiting period.
Your journey begins with a consultation with one of our obstetricians, who will review your medical history, confirm your gestational age, and assess any previous screening results. This ensures that the NIPT test is appropriate for your stage of pregnancy and individual health profile.
A single 10ml blood sample is drawn from the mother's arm in a straightforward, routine procedure. No preparation is required, and the process takes only a few minutes.
The blood sample is sent to our advanced laboratory, where cell-free fetal DNA is extracted and analyzed for chromosomal abnormalities using cutting-edge DNA sequencing technology. Every sample is handled with the utmost care to ensure accurate and reliable results.
Results are delivered within 5–7 working days. Our specialists will conduct a detailed follow-up consultation to explain your findings clearly and compassionately. If results indicate a higher risk, our team will guide you through the available confirmatory testing options and next steps, providing both medical expertise and emotional support throughout.
| Aspect | NIPT Test | Traditional Prenatal Screening |
|---|---|---|
| Accuracy | >99% detection rate for T21 | 70–85% accuracy depending on gestational age |
| Safety | Non-invasive; no risk to mother or baby | Non-invasive but lower sensitivity |
| Timing | From 10 weeks of pregnancy | Usually between 11 and 14 weeks |
| Result Time | 5–7 working days | 1–2 weeks |
| Need for Further Testing | Only if the results are high-risk | Often requires follow-up diagnostic tests |
In Hong Kong, NIPT test costs range from HK$2700 to HK$8000+, depending on the panel and inclusion of extra conditions like sex chromosome abnormalities. Amber Health offers transparent, all-inclusive pricing covering consultation, lab analysis, and counseling. Contact us for a personalized quote or to book a free consultation.
While both the NIPT and T21 tests are non-invasive and rely on fetal DNA analysis from a maternal blood sample, they differ in scope and focus.
The NIPT test provides comprehensive chromosomal screening across multiple conditions, including Trisomy 21, Trisomy 18, Trisomy 13, and select sex chromosome abnormalities, making it the preferred choice for expectant mothers seeking a broad overview of their baby's chromosomal health.
The T21 test, by contrast, is specifically designed to detect Trisomy 21 (Down Syndrome), offering a more targeted and often more cost-effective approach for mothers whose primary concern is Down Syndrome.
While the NIPT test is available to most expectant mothers, it is highly recommended for women aged 35 or older, those with previous abnormal screening results, and individuals with a personal or family history of chromosomal conditions. It is also the preferred non-invasive, highly accurate alternative to diagnostic procedures.
A high-risk result indicates an elevated probability of a chromosomal abnormality, not a definitive diagnosis, and requires further investigation. Our specialists will discuss confirmatory options like amniocentesis or genetic counselling, providing continuous medical and emotional support as you navigate the next steps.
Yes. If you select a panel that includes sex chromosome analysis, the NIPT can determine the baby's sex. This is optional; parents who prefer not to know can request that this information be withheld. Please discuss your preference with our team during your initial consultation.